Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD

Neurotoxicity Research

Volumn 6, Issue 7-8, 2004, Pages 523-533

  Jana, Nihar Ranjan ^a   Nukina, Nobuyuki ^b  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Ataxin 3; Misfolding; Polyglutamine; Ubiquitination

Indexed keywords

ATXN3 PROTEIN, HUMAN; MJD PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN; PEPTIDE; POLYGLUTAMINE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN;

ANIMAL; ARTICLE; CELL DEATH; CELL LINE; COMPARATIVE STUDY; GENETICS; MACHADO JOSEPH DISEASE; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FOLDING; TRINUCLEOTIDE REPEAT;

ANIMALS; CELL DEATH; CELL LINE; MACHADO-JOSEPH DISEASE; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITINS;

EID: 15844372659     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033448     Document Type: Article

References (43)

1. Chai Y, SL Koppenhafer, NM Bonini and HL Paulson (1999a) Analysis of the role of heat shock protein (hsp) molecular chaperones in polyglutamine disease. J. Neurosci. 19, 10338-10347.
2. Chai Y, SL Koppenhafer, SJ Shoesmith, MK Perez and HL Paulson (1999b) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673-682.
3. Cummings CJ and HY Zoghbi (2000) Fourteen and counting: Unraveling trinucleotide repeat diseases. Hum. Mol. Genet. 9, 909-916.
4. Cummings CJ, MA Mancini, B Antalffy, DB DeFranco, HT Orr and HY Zoghbi (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19, 148-154.
5. Cummings CJ, E Reinstein, Y Sun, B Antalffy, Y-H Jiang, A Ciechanover, HT Orr, AL Beaudet and H Zoghbi (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879-892.
6. DiFiglia M, E Sapp, KO Chase, SW Davies, GP Bates, JP Vonsattel and N Aronin (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
7. Ellerby LM, RL Andrusiak, CL Wellington, AS Hackam, SS Propp, JD Wood, AH Sharp, RL Margolis, CA Ross, GS Salvesen, MR Hayden and DE Bredesen (1999a) Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J. Biol. Chem. 274, 8730-8736.
8. Ellerby LM, AS Hackam, SS Propp, HM Ellerby, S Rabizadeh, NR Cashman, M A Trifiro, L Pinsky, CL Wellington, GS Salvesen, MR Hayden and DE Bredesen (1999b) Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cyto toxicity. J. Neurochem. 72, 185-195.
9. Ferrigno P and PA Silver (2000) Polyglutamine expansions: Proteolysis, chaperones, and the dangers of promiscuity. Neuron 26, 9-12.
10. Goldberg YP, DW Nicholson, MA Rasper, MA Kalchman, HB Koide, RK Graham, M Bromm, P Kazemi-Esfarjani, NA Thornberry, JP Vaillancourt and MR Hayden (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442-449.
11. Hayashi M, K. Kobayashi and H. Furata (2003) Immunohistochemical study of neural intranuclear and cytoplasmic inclusions in Machando-Joshep disease. Phychiatry Clin. Neurosci. 57, 205-213.
12. Heiser V, E Scherzinger, A Boeddrich, E Nordhoff, R Lurz, N Schugardt, H Lehrach and EE Wanker (2000) Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy. Proc. Natl. Acad. Sci. USA 97, 6739-6744.
13. Huynh DP, K Figueroa, N Hoang and S-M Pulst (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nature Genet. 26, 44-50.
14. Jana NR, M Tanaka, G Wang and N Nukina (2000) Polyglutamine length-dependent interaction of Hsp70 and Hsp40 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018.
15. Jana NR, EA Zemskov, G Wang and N Nukina (2001) Altered proteasomal function due to the expression of polyglutamine expanded truncated huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 1049-1059.
16. Kahlem P, C Terre, H Green and P Djian (1996) Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA 93, 14580-14585.
17. Kawaguchi Y, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Makamura, M Nishimura et al. (1994) CAG expansion in a novel gene for Machando-Joshep disease at chromosome 14q32.1. Nature Genet. 8, 221-228.
18. Kim TW and RE Tanzi (1998) Neuronal intranuclear inclusions in polyglutamine diseases: Nuclear weapons or nuclear fallout? Neuron 21, 657-659.
19. Li X-J, S-H Li, AH Sharp, FC Nucifora, G Schilling, A Lanahan, P Worley, SH Snyder and CA Ross (1995) A huntingtin associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
20. Lin X, CJ Cummings and HY Zoghbi (1999) Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24, 499-502.
21. Mende-Mueller LM, T Toneff, S-R Hwang, M-F Chesselet and VYH Hook (2001) Tissue-specific proteolysis of huntingtin (htt) in the human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J. Neurosci. 21, 1830-1837.
22. Paulson HL (1999) Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the misfold. Am. J. Hum. Genet. 64, 339-345.
23. Paulson HL and KH Fischbeck (1996) Trinucleotide repeats in neurogenetic disorders. Ann. Rev. Neurosci. 19, 79-107.
24. Paulson HL, SS Das, PB Crino, MK Perez, SC Patel, D Gotsdiner, KH Fischbeck and RN Pittman (1997) Machando-Joshep disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol. 41, 453-462.
25. Perez MK, HL Paulson and RN Pittman (1999) Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum. Mol. Genet. 8, 2377-2385.
26. Perutz MF, T Johnson, M Suzuki and JT Finch (1994) Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91, 5355-5358.
27. Reddy PS and DE Housman (1997) The complex pathology of trinucleotide repeats. Curr. Opin. Cell. Biol. 9, 364-372.
28. Rosenberg RN (1992) Machando-Joshep disease: An autosomal dominant motor system degeneration. Mov. Disord. 7, 193-203.
29. Ross CA. (1997) Intranuclear neuronal inclusions: A common pathogenic mechanism of glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
30. Saudou F, S Finkbeiner, D Devys and ME Greenberg (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
31. Sherman MY and AL Goldberg (2001) Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 29, 15-32.
32. Sittler A, S Walter, N Wedemeyer, R Hasenbank, E Scherzinger, H Eickhoff, GP Bates, H Lehrach and EE Wanker (1998) SH3GL3 associates with the huntingtin exon-1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell 2, 427-436.
33. Stenoien DL, CJ Cummings, HP Adams, MG Mancini, K Patel, GN DeMartino, M Marcelli, NL Weigel and MA Mancini (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 8, 731-741.
34. Stott K, JM Blackburn, PJG Butler and M Perutz (1995) Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 92, 6509-6513.
35. Tait D, M Riccio, A Sittler, E Scherzinger, S Santi, A Ognibene, NM Maraldi, H Lehrach and EE Wanker (1998) Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet. 7, 991-997.
36. Trottier Y, Y Lutz, G Stevanin, G Imbert, D Devys, G Cancel, F Saudou, C Weber, G David, L Tora, Y Agid, A Brice and J-L Mandel (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403-405.
37. Wang G, K Ide, N Nukina, J Goto, Y Ichikawa, K Uchida, T Sakamoto and I Kanazawa (1997) Machando-Joseph disease gene product identified in lymphocytes and brain. Biochem. Biophys. Res. Commun. 233, 476-479.
38. Wang GH, K Mitsui, S Kotliarova, A Yamashita, Y Nagao, S Tokuhiro, T Iwatsubo, I Kanazawa and N Nukina (1999) Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. NeuroReport 10, 2435-2438.
39. Wang GH, N Sawai, S Kotliarova, I Kanazawa and N Nukina (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum. Mol. Genet. 9, 1795-1803.
40. Warrick JM, HYE Chan, GL Gray-Board, Y Chai, HL Paulson and NM Bonini (1999) Suppression of polyglutamine-mediated neurodegeneration in drosophila by the molecular chaperone Hsp70. Nature Genet. 23, 425-428.
41. Wellington CL, LM Ellerby, AS Hackam, RL Margolis, MA Trifiro R Singaraja, K McCutcheon, GS Salvesen, SS Propp, M Bromm, KJ Rowland, T Zhang, D Rasper, S Roy, N Thornberry, L Pinsky, A Kakizuka, CA Ross, DW Nicholson, DE Bredesen and MR Hayden (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167.
42. Wellington CL, R Singaraja, L Ellerby, J Savill, S Roy, B Leavitt, E Cattaneo, A Hackam, A Sharp, N Thornberry, DW Nicholson, DE Bredesen and MR Hayden (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol Chem. 275, 19831-19838.
43. Zoghbi HY and HT Orr (2000) Glutamine repeats and neurodegeneration. Ann. Rev. Neurosci. 23, 217-247.